SpectronRx
spectronrx.com
Healthcare & Life Sciences Consulting
Nuclear Energy
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
SpectronRx commences mass production of high-purity Actinium-225, to strengthen global supply for cancer therapies
SpectronRx commences mass production of high-purity Actinium-225, to strengthen global supply for cancer therapies
Read more
Report
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
media457686
Read more
Report
Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership
Partnership will expand Plus' capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancyAUSTIN, Texas and INDIANAPOLIS, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Na
Read more
Report
CDMO SpectronRx homes in on completion of European plant to crank out key radiopharma isotope
Read more
Report
SpectronRx and ARTBIO Join Forces to Develop and Manufacture Clinical Supply of Novel Alpha Radioligand Therapy AB001 for Indiana and Surrounding States
Read more
Report
SpectronRx and RLS Team Up to Give the Radiopharmaceutical Pipeline and Supply Chain a Much-Needed Boost
Read more
Report
SpectronRx Receives U.S. Nuclear Regulatory Commission Materials License for New Facility
Leading Radiopharma CDMO Opens Second Location
Read more
Report
SpectronRx Receives U.S. Nuclear Regulatory Commission Materials License for New Facility
Leading Radiopharma CDMO Opens Second Location
Read more
Report